Vasoactive intestinal peptide: a novel neurotrophic factor

被引：5
|
作者：
Gressens, P
机构：
[1] Hop Robert Debre, Serv Neurol Pediat, F-75019 Paris, France
[2] Hop Robert Debre, INSERM, CRI 97 01, F-75019 Paris, France
来源：
ARCHIVES DE PEDIATRIE | 1998年 / 5卷 / 06期
关键词：
brain; developmental biology; receptors; sensory; vasoactive intestinal peptide;
D O I：
10.1016/S0929-693X(98)80174-7
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Vasoactive intestinal peptide (VIP) is a 28-amino acid neuropeptide with potent growth-related actions on dissociated neural cells. In recent years its role in brain development was been elucidated: VIP has been shown to be a regulator of early neurodevelopment and embryonic growth, a stimulator of neocortical astrocytogenesis and a neuroprotective molecule against excitotoxic and other neurotoxic substances. Thus VIP appears as a fundamental regulator of brain growth and development, and a potent neuroprotective agent possibly involved in pathological processes such as microcephalies and some neurological impairments observed in very premature babies. Similarly, VIP and VIP derivatives could represent a new avenue in the search of therapeutics for excitotoxic lesions of the developing brain. (C) 1998, Elsevier, Paris.
引用
收藏
页码：654 / 660
页数：7
相关论文
共 50 条
  • [41] Parasympathetic vasoactive intestinal peptide (VIP): a likely contributor to clozapine-induced sialorrhoea
    Ekstrom, J.
    Godoy, T.
    Loy, F.
    Riva, A.
    ORAL DISEASES, 2014, 20 (03) : e90 - e96
  • [42] MOLECULAR-PROPERTIES OF THE VASOACTIVE-INTESTINAL-PEPTIDE RECEPTOR IN AORTA AND OTHER TISSUES
    SHREEVE, SM
    DELUCA, AW
    DIEHL, NL
    KERMODE, JC
    PEPTIDES, 1992, 13 (05) : 919 - 926
  • [43] Serum Vasoactive Intestinal Peptide as a Novel Biomarker for Low-Voltage Areas in Patients With Atrial Fibrillation
    Nishino, Kotaro
    Temma, Taro
    Natsui, Hiroyuki
    Watanabe, Masaya
    Nakao, Motoki
    Kawasaki, Masahiro
    Shimano, Kintaro
    Kawakami, Kei
    Saito, Shota
    Koya, Jiro
    Tatsuta, Daishiro
    Koizumi, Takuya
    Kadosaka, Takahide
    Koya, Taro
    Tsuneta, Satonori
    Kamiya, Kiwamu
    Nagai, Toshiyuki
    Anzai, Toshihisa
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (07):
  • [44] Expression of motilin and vasoactive intestinal peptide in diverticular disease of the colon
    Osadchuk, Mikhail A.
    Mironova, Ekaterina D.
    Krylova, Iuliia S.
    Gulyaev, Pavel, V
    Akhtyamova, Regina A.
    TERAPEVTICHESKII ARKHIV, 2024, 96 (02) : 97 - 101
  • [45] A recombinant adenoviral vector encoding functional vasoactive intestinal peptide
    Lodde, BM
    Delporte, C
    Goldsmith, CM
    Tak, PP
    Baum, BJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 319 (01) : 189 - 192
  • [46] Vasoactive intestinal peptide differentially modulates human immunoglobulin production
    Kimata, H
    ADVANCES IN NEUROIMMUNOLOGY, 1996, 6 (01): : 107 - 115
  • [47] REGIONAL DISTRIBUTION OF VASOACTIVE-INTESTINAL-PEPTIDE IMMUNOREACTIVITY IN THE BRAIN OF SALMON, TROUT AND CARP
    CANCIGLIA, P
    MARTIN, JL
    BOLIS, CL
    RANDALL, D
    MAGISTRETTI, PJ
    BIOLOGICAL SIGNALS, 1995, 4 (02): : 86 - 93
  • [48] Design, Recombinant Fusion Expression and Biological Evaluation of Vasoactive Intestinal Peptide Analogue as Novel Antimicrobial Agent
    Xu, Chunlan
    Guo, Yu
    Qiao, Xiangjin
    Shang, Xiaoya
    Niu, Weining
    Jin, Mingliang
    MOLECULES, 2017, 22 (11):
  • [49] VASOACTIVE-INTESTINAL-PEPTIDE RECEPTOR EXPRESSION ON HUMAN LYMPHOBLASTS
    ODORISIO, MS
    SHANNON, BT
    MULNE, AF
    ZWICK, D
    GROSSMAN, NJ
    RUYMANN, FB
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1992, 14 (02): : 144 - 150
  • [50] Vasoactive intestinal peptide as a healing mediator in Crohn's disease
    Arranz, A.
    Abad, C.
    Juarranz, Y.
    Leceta, J.
    Martinez, C.
    Gomariz, P.
    NEUROIMMUNOMODULATION, 2008, 15 (01) : 46 - 53
12345